𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Growth retardation in pediatric Crohn's disease: Pathogenesis and interventions

✍ Scribed by Raanan Shamir; Moshe Phillip; Arie Levine

Publisher
John Wiley and Sons
Year
2007
Tongue
English
Weight
221 KB
Volume
13
Category
Article
ISSN
1078-0998

No coin nor oath required. For personal study only.

✦ Synopsis

Growth retardation (GR) may pose a significant challenge to the quality of life and the proper management of children and adolescents with Crohn's disease (CD). It can occur in a significant proportion of patients, and may precede clinical evidence of bowel disease. Current evidence suggests that GR is a complex interaction between nutritional status, inflammation, disease severity, and genotype, which causes resistance to the effects of growth hormone. Recent research has identified a key role for the inflammatory cytokines TNF alpha, IL-6, and IL1 beta. This review summarizes current knowledge as well as gaps in our understanding of the mechanisms involved and the usefulness of the different treatment modalities in promoting growth in CD patients.

πŸ“œ SIMILAR VOLUMES

Tolerance and efficacy of azathioprine i
Tolerance and efficacy of azathioprine in pediatric Crohn's disease
✍ Laura Riello; CΓ©cile Talbotec; HΓ©lΓ¨ne Garnier-LenglinΓ©; BΓ©nΓ©dicte Pigneur; Johan πŸ“‚ Article πŸ“… 2011 πŸ› John Wiley and Sons 🌐 English βš– 131 KB πŸ‘ 2 views

## Background: Thiopurines are considered first-line immunomodulators for the prevention of relapse in moderate to severe pediatric crohn's disease (cd). early introduction of thiopurines was shown in a pediatric trial to maintain steroid-free remission in 90% of patients for 18 months. in the pres

Innate dysfunction promotes linear growt
Innate dysfunction promotes linear growth failure in pediatric Crohn's disease and growth hormone resistance in murine ileitis
✍ Sharon D'Mello; Anna Trauernicht; Anne Ryan; Erin Bonkowski; Tara Willson; Bruce πŸ“‚ Article πŸ“… 2012 πŸ› John Wiley and Sons 🌐 English βš– 424 KB πŸ‘ 1 views

Background: Growth failure remains a common complication of pediatric Crohn's disease (CD) and has been associated with small bowel involvement and need for surgery. We have reported that patients with elevated (!1.6 lg/mL) granulocyte macrophage colony stimulating factor autoantibodies (GM-CSF Ab)

Intestinal ferroportin expression in ped
Intestinal ferroportin expression in pediatric Crohn's disease
✍ Tyler Burpee; Paul Mitchell; Douglas Fishman; Shabana Islam; Elizabeta Nemeth; M πŸ“‚ Article πŸ“… 2011 πŸ› John Wiley and Sons 🌐 English βš– 133 KB πŸ‘ 2 views

Background: Anemia is a frequent complication of Crohn's disease (CD). The intestinal iron exporter ferroportin (FPN) is involved in both iron deficiency anemia and the anemia of chronic disease. To examine its role in CD, intestinal FPN expression was studied in subjects with and without CD. Metho

Thrombin generation in pediatric patient
Thrombin generation in pediatric patients with Crohn's disease
✍ Heike Bernhard; Andrea Deutschmann; Bettina Leschnik; Sabrina Schweintzger; Mich πŸ“‚ Article πŸ“… 2011 πŸ› John Wiley and Sons 🌐 English βš– 291 KB πŸ‘ 2 views

Background: Patients with inflammatory bowel disease (IBD) have an increased risk of thromboembolic complications. The pathogenesis of IBD is not really clear and a high thrombin activity might contribute to the pathogenesis. We measured thrombin generation by means of calibrated automated thrombogr

Osteoprotegerin in pediatric Crohn's dis
Osteoprotegerin in pediatric Crohn's disease and the effects of exclusive enteral nutrition
✍ Lily Nahidi; Steven T. Leach; Marc A. Sidler; Alon Levin; Daniel A. Lemberg; And πŸ“‚ Article πŸ“… 2011 πŸ› John Wiley and Sons 🌐 English βš– 153 KB πŸ‘ 1 views

Background: Osteoprotegerin (OPG) may have proinflammatory roles in addition to its contribution to the maintenance of bone mass. Exclusive enteral nutrition (EEN) is an established therapy for the induction of remission in Crohn's disease (CD). The aims of this study were to ascertain serum, fecal,